Biotech | December 13, 2021
Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
It is a novel oral NLRP3 inflammasome inhibitor
It is a novel oral NLRP3 inflammasome inhibitor
The first hospital in Kharadi launched three years ago has made a significant difference to women and children's health
The 50-bed hospital is positioned to address complexities specific to women and children, going beyond a birthing facility
Carestream equipment is highly recommended for its imaging quality
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Collaboration designed to bring reproductive health screening capabilities to hospitals and clinics across the country
Subscribe To Our Newsletter & Stay Updated
